<SEC-DOCUMENT>0001973379-25-000149.txt : 20250508
<SEC-HEADER>0001973379-25-000149.hdr.sgml : 20250508
<ACCEPTANCE-DATETIME>20250508143417
ACCESSION NUMBER:		0001973379-25-000149
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250508
DATE AS OF CHANGE:		20250508

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TEVA PHARMACEUTICAL INDUSTRIES LTD
		CENTRAL INDEX KEY:			0000818686
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-16174
		FILM NUMBER:		25925384

	BUSINESS ADDRESS:	
		STREET 1:		TEVA PHARMACEUTICAL INDUSTRIES LIMITED
		STREET 2:		124 DVORA HANEVI'A ST.
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6944020
		BUSINESS PHONE:		972 (3) 914-8213

	MAIL ADDRESS:	
		STREET 1:		TEVA PHARMACEUTICAL INDUSTRIES LIMITED
		STREET 2:		124 DVORA HANEVI'A ST.
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6944020

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sabag Mark
		CENTRAL INDEX KEY:			0001721442
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		144

	MAIL ADDRESS:	
		STREET 1:		5 BASEL STREET, P.O. BOX 3190
		CITY:			PETACH TIKVA
		STATE:			L3
		ZIP:			4951033
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001721442</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0000818686</issuerCik>
      <issuerName>TEVA PHARMACEUTICAL INDUSTRIES LTD</issuerName>
      <secFileNumber>001-16174</secFileNumber>
      <issuerAddress>
        <com:street1>TEVA PHARMACEUTICAL INDUSTRIES LIMITED</com:street1>
        <com:street2>124 DVORA HANEVI'A ST.</com:street2>
        <com:city>TEL AVIV</com:city>
        <com:stateOrCountry>L3</com:stateOrCountry>
        <com:zipCode>6944020</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>972 (3) 914-8213</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Sabag Mark</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
        <relationshipToIssuer>EXECUTIVE VICE PRESIDENT INTL MARKETS COMMERCIAL</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>ORDINARY SHARES</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>CITIGROUP GLOBAL MARKETS</name>
        <address>
          <com:street1>390 GREENWICH STREET</com:street1>
          <com:city>NEW YORK</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10013</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>337915</noOfUnitsSold>
      <aggregateMarketValue>6097323.73</aggregateMarketValue>
      <noOfUnitsOutstanding>1146959855</noOfUnitsOutstanding>
      <approxSaleDate>05/08/2025</approxSaleDate>
      <securitiesExchangeName>NYSE</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>ORDINARY SHARES</securitiesClassTitle>
      <acquiredDate>03/06/2023</acquiredDate>
      <natureOfAcquisitionTransaction>SHARES FROM ROLLOVER</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>TEVA PHARMACEUTICALS INDUSTRIES LIMITED</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>337915</amountOfSecuritiesAcquired>
      <paymentDate>05/07/2025</paymentDate>
      <natureOfPayment>COMPENSATION</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>MARK SABAG</name>
        <address>
          <com:street1>124 DVORA HANEVI'A ST.</com:street1>
          <com:city>TEL AVIV</com:city>
          <com:stateOrCountry>L3</com:stateOrCountry>
          <com:zipCode>6944020</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>ORDINARY SHARES</securitiesClassTitle>
      <saleDate>02/12/2025</saleDate>
      <amountOfSecuritiesSold>177626</amountOfSecuritiesSold>
      <grossProceeds>2886555.72</grossProceeds>
    </securitiesSoldInPast3Months>
    <remarks>UNDER SECURITIES TO BE SOLD DATE ACQUIRED WERE VARIOUS DATES AND YEARS FROM 2023 TO 2025</remarks>
    <noticeSignature>
      <noticeDate>05/08/2025</noticeDate>
      <signature>CONFORMED SIGNATURE ON FILE</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
